RU2002105930A - Preservative for washed red blood cells - Google Patents

Preservative for washed red blood cells

Info

Publication number
RU2002105930A
RU2002105930A RU2002105930/15A RU2002105930A RU2002105930A RU 2002105930 A RU2002105930 A RU 2002105930A RU 2002105930/15 A RU2002105930/15 A RU 2002105930/15A RU 2002105930 A RU2002105930 A RU 2002105930A RU 2002105930 A RU2002105930 A RU 2002105930A
Authority
RU
Russia
Prior art keywords
preservative
blood cells
red blood
washed red
disubstituted
Prior art date
Application number
RU2002105930/15A
Other languages
Russian (ru)
Other versions
RU2225692C2 (en
Inventor
Евгений Алексеевич Селиванов
Вера Николаевна Мельникова
Виктор Тимофеевич Плешаков
Original Assignee
Российский научно-исследовательский институт гематологии и трансфузиологии
Filing date
Publication date
Application filed by Российский научно-исследовательский институт гематологии и трансфузиологии filed Critical Российский научно-исследовательский институт гематологии и трансфузиологии
Priority to RU2002105930/15A priority Critical patent/RU2225692C2/en
Priority claimed from RU2002105930/15A external-priority patent/RU2225692C2/en
Publication of RU2002105930A publication Critical patent/RU2002105930A/en
Application granted granted Critical
Publication of RU2225692C2 publication Critical patent/RU2225692C2/en

Links

Claims (1)

Консервант для отмытых эритроцитов, содержащий растворенные в воде очищенный деионизированный частично деструктуризированный желатин с молекулярной массой 13000-20000 Да, хлорид натрия, двузамещенный цитрат натрия и двузамещенный фосфат натрия, отличающийся тем, что он дополнительно содержит глюкозу, причем компоненты взяты в следующем соотношении, г/л:Preservative for washed red blood cells containing purified, deionized partially destructured gelatin with a molecular weight of 13000-20000 Da dissolved in water, sodium chloride, disubstituted sodium citrate and disubstituted sodium phosphate, characterized in that it additionally contains glucose, and the components are taken in the following ratio, g / l: Желатин очищенный деионизированный частично деструктуризированный с молекулярной массой 13000-20000 Да 7,2-8,8Purified gelatin deionized partially destructured with a molecular weight of 13000-20000 Yes 7.2-8.8 Цитрат натрия 0,9-1,1Sodium Citrate 0.9-1.1 Хлорид натрия 3,5-4,0Sodium Chloride 3.5-4.0 Двузамещенный фосфат натрия 3,6-4,4Disubstituted Sodium Phosphate 3.6-4.4 Глюкоза 6,3-7,7Glucose 6.3-7.7 Вода для инъекций До 1 лWater for injection Up to 1 L
RU2002105930/15A 2002-03-05 2002-03-05 Preserving agent for washed out erythrocytes RU2225692C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2002105930/15A RU2225692C2 (en) 2002-03-05 2002-03-05 Preserving agent for washed out erythrocytes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2002105930/15A RU2225692C2 (en) 2002-03-05 2002-03-05 Preserving agent for washed out erythrocytes

Publications (2)

Publication Number Publication Date
RU2002105930A true RU2002105930A (en) 2003-11-10
RU2225692C2 RU2225692C2 (en) 2004-03-20

Family

ID=32390260

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002105930/15A RU2225692C2 (en) 2002-03-05 2002-03-05 Preserving agent for washed out erythrocytes

Country Status (1)

Country Link
RU (1) RU2225692C2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115777695B (en) * 2023-02-07 2023-05-12 成都海默云因医学检验实验室有限公司 Composite preservation solution suitable for cerebrospinal fluid cell morphology examination and preparation method thereof

Similar Documents

Publication Publication Date Title
CN104774896A (en) Preparation method for iron-chelated collagen peptide of hairtail fish-bones
DE60021734D1 (en) VISCOSITY-DANDARDIZED COMPOSITIONS TO SIMPLIFY SWALLOWING IN DYSPHAGIC PATIENTS
NO20022201L (en) Solutions containing Epinastine
SE0003616D0 (en) Pharmaceutically acceptable starch
CO5540278A2 (en) PHARMACEUTICAL FORMULATION OF MASKED FLAVOR AND PROCEDURE FOR PREPARATION
ES2372696T3 (en) PHYSIOLOGICALLY ACTIVE COMPOSITION AND PROCESS TO PRODUCE THE SAME.
RU2002105930A (en) Preservative for washed red blood cells
ATE59554T1 (en) PHARMACEUTICAL COMPOSITIONS BASED ON MERCAPTOETHANESULPHONIC ACIDS, ORGANIC DERIVATIVES OF MERCAPTOETHANESULPHONIC ACIDS AND PROCESSES FOR THEIR PREPARATION.
JP2002201141A5 (en)
JP2000355533A5 (en)
Varol et al. Water-borne fluoride and primary hypertension
WO2001021795A3 (en) Fatty acid transport proteins
RU98119668A (en) METHOD FOR IMPROVING RESISTANCE TO HEMOLYSIS OF ERYTHROCYTES AND RESTORING THEIR DAMAGED FORM
CN213820402U (en) Dampproofing mould proof device of wardrobe
RU98105049A (en) ANTISISCHEMIC AND ANTIATHEROSCLEROTIC MEDICINE
RU2005123964A (en) METHOD FOR INCREASING THE RESISTANCE OF ERYTHROCYTES TO HEMOLYSIS INDUCED BY ETHANOL
RU2002109127A (en) Drops of Makarov-Soloviev
RU2002129335A (en) OPHTHALMIC IRRIGATION SOLUTION
RU98113165A (en) Stable aqueous solution of erythropoietin
EA200100164A1 (en) APPLICATION OF GLUCOSE CAPTURE AMPLIFIER TO REDUCE POSTYSHEMIC HEART DAMAGE
RU2002130259A (en) Antitumor agent
Bernard et al. Cytochemical localization of polysaccharides in bacteria
Sugai et al. Actinomycin D inhibition of intestinal transport of L-histidine and of vitamin D action
RU2001134577A (en) Bravinton infusion solution to improve cerebral circulation
KR960021035A (en) Method of manufacturing skin disease treatment